Campbell & Co Investment Adviser’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$3.7M	Buy	412,518 +390,834	+1,802%	+$3.5M	0.23%	85
2025 Q1	$163K	Buy	+21,684	New	+$163K	0.01%	963
2024 Q1	–	Sell	-20,702	Closed	-$124K	–	1107
2023 Q4	$124K	Buy	+20,702	New	+$124K	0.01%	1056